Antimicrobial Agents and Chemotherapy · 2004 · 16 citations · 7 references
PharmacyPharmacokineticsPharmacologyAntimicrobial PharmacologyPulmonary Drug DeliveryRespiratory PharmacotherapyMechanical VentilationPneumonia PharmacotherapyPulmonary PharmacokineticsRespiratory MedicineRespiratory PharmacologyBronchial SecretionsPulmonary DistributionVentilator-associated PneumoniaVentilator-associated Pneumonia Treatment
The pharmacokinetics of moxifloxacin was studied in 17 mechanically ventilated patients with pneumonia. Patients were given 400 mg of moxifloxacin intravenously. Blood samples and bronchial secretions were taken on days 1 and 4. A dose of 400 mg of moxifloxacin allows one to achieve efficient concentrations in bronchial secretions and plasma.
7
Daren K. Heyland, Lauren E. Griffith, Sean Keenan et al. · American Journal of Respiratory and Critical Care Medicine · 1999 · 830 citations
R. Finch, Dirk Schürmann, Owen Collins et al. · Antimicrobial Agents and Chemotherapy · 2002 · 184 citations · Full text
Ashish Soman, D. Honeybourne, J. M. Andrews et al. · Journal of Antimicrobial Chemotherapy · 1999 · 156 citations · Full text